An accurate mass fever detecting solution from Asqella Ltd

Asqella Oy has received a prominent R&D grant to develop applicability to indicate infectious symptoms with its submillimetre-wave thermography solution. The grant was received from Business Finland, the Finnish government organization for innovation funding.

The objective is to provide a new fever detection feature to augment the capabilities of Asqella’s flagship product, the concealed threat detection system ARGON. In urban crowded places quick throughput of people is essential. The accurate mass fever detection can provide significant added value for counter pandemic applications.

 

Press Release 8.5.2020 An accurate mass fever detecting solution from Asqella Ltd

The Company’s submillimetre-wave camera Argon has been used in the past to detect threats such as weapons or explosives, hidden under clothing. Now Asqella is going to provide also a highly accurate solution for the detection of people with fever in order to limit the spread of influenza-like diseases such as Covid-19.

“Unlike traditional infrared thermography systems, Asqella’s revolutionary passive submmwave camera technology can perform thermography on people, as clothing materials are transparent at this wavelength range. As the method is passive, the subjects are not exposed to any external source of radiation, and only the naturally emitted body heat is measured.”, CEO Arttu Luukanen explains.

The company believes that such a capability could provide significant added value to several market segments, for example in the screening of cruise line passengers before boarding, entry screening at border crossings as well as other mass gatherings. Many airline companies have also informed that they will start to screen for febrile persons amongst their passengers.

Studies have shown that infrared thermometry is a highly inaccurate and ineffective method for detecting febrile persons. The measurement can only be performed from areas of body not covered by clothing, and in practice is limited to the persons’ face only. “Facial infrared temperature is however strongly affected by a number of factors, such as the person’s age, eyewear, perspiration and even makeup. Point measurement methods, such as aural temperature measurement may yield more accurate results, but are far too slow methods to be performed on large numbers of people effectively.”, Luukanen claims.

Asqella Oy has received a prominent R&D grant from Business Finland. Thanks to the grant Asqella estimates to have results in couple of weeks to verify the applicability of submillimetre-wave thermography as an indicator of infectious symptoms. The objective is to provide a new fever detection feature to augment the capabilities of their concealed threat detection systems.

For more information, contact:
Arttu Luukanen
Managing Director
[email protected]
+358 10 524 1890